Acute aerobic exercise ameliorates craving and attentional function in individuals with methamphetamine use disorders  Physiology and Behavior. 2025;290:114775
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39631450

Audio-Based Care for Managing Mental Health and Substance Use Disorders in Adults: A Systematic Review  Medical Care. 2025;63(2):134-151
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39791847

Brain-derived neurotrophic factor levels in morphine-addicted rodents under different exercise protocols: a systematic review and meta-analysis  World Journal of Biological Psychiatry. 2025;26(2):92-102
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39829043

Cannabis consumption and risk of asthma: a systematic review and meta-analysis  BMC Pulmonary Medicine. 2025;25(1):48
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39881272

Drug delivery strategies for the treatment of relapse behavior in substance use disorder- A systematic review  Metabolic Brain Disease. 2025;40(1):104
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39820990

Effect of E-learning clinical management of substance-dependent pregnant women on the knowledge and clinical skill performance of midwives: a randomized controlled trial  BMC Pregnancy and Childbirth. 2025;25(1):11
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39780073

Evaluating Delta-8-THC-Induced Psychosis: A Systematic Review  Clinical Neuropharmacology. 2025;48(1):20-23
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39805119

Exploring heterogeneity in recovery from substance use disorder following mindfulness-based relapse prevention: A latent profile analysis  J Subst Use Addict Treat. 2025;169:209537
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39389547

GLP-1 weight loss drugs could help people with impulse control and addiction disorders, say researchers  BMJ - 20 January 2025;388:r123
https://login.smhslibresources.health.wa.gov.au/login?url=https://www.bmj.com/content/bmj/388/bmj.r123.full.pdf

Healthcare professionals advised to ask people about gambling at health checks and GP appointments. National Institute for Health and Care Excellence, 28 January 2025
https://www.nice.org.uk/news/articles/nice-recommends-healthcare-professionals-ask-people-about-gambling-at-health-checks-and-gp-appointments

Identifying standardised neuropsychological test measures sensitive to cannabis consumption: A systematic review Journal of Affective Disorders. 2025;369:772-781
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39419188

Implicit Racial Bias in Evaluation of Neonatal Opioid Withdrawal Syndrome  J Racial Ethn Health Disparities. 2025;12(1):473-479
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38110799

The Improvement Effects of Weizmannia coagulans BC99 on Liver Function and Gut Microbiota of Long-Term Alcohol Drinkers: A Randomized Double-Blind Clinical Trial  Nutrients. 2025;17(2)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39861457

An initial randomized controlled trial of a Combined Medication and Behavioral Activation Treatment (CoMBAT) for people with opioid use disorder  J Subst Use Addict Treat. 2025;169:209602
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39672333

Management of alcohol withdrawal syndromes in general hospital settings  BMJ. 2025;388:e080461
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39778965

Mapping the effectiveness and risks of GLP-1 receptor agonists  Nature Medicine - 20 January 2025
https://login.smhslibresources.health.wa.gov.au/login?url=https://doi.org/10.1038/s41591-024-03412-w

mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder  Addiction Science & Clinical Practice. 2025;20(1):6
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39881397

Mindfulness Training vs Recovery Support for Opioid Use, Craving, and Anxiety During Buprenorphine Treatment: A Randomized Clinical Trial  JAMA Netw Open. 2025;8(1):e2454950
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39836426

Outcomes and Challenges of Motivational Interviewing in Dual Diagnosis Treatment-A Systematic Review  Journal of Dual Diagnosis. 2025;21(1):56-69
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39798118

Pharmacological treatments for co-occurring PTSD and substance use disorders: A systematic review  J Subst Use Addict Treat. 2025;169:209601
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39672336

Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trial  Alcohol and Alcoholism. 2025;60(2)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39829301

Prevalence, characteristics and outcomes of patients with metabolic and alcohol related/associated liver disease (MetALD): a systematic review and meta-analysis  Metabolism: Clinical and Experimental. 2025;163:156101
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39662742

Quit attempts, use of smoking cessation treatments and quitting intention among treatment seekers in rural areas  J Subst Use Addict Treat. 2025;169:209603
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39672339

Review of Evidence on Alcohol and Health. Washington, DC: The National Academies Press; 2025 
Available from: https://doi.org/10.17226/28582

The Role of Propofol in Alcohol Withdrawal Syndrome: A Systematic Review  Journal of Clinical Pharmacology. 2025;65(2):170-178
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39415533

Six-fold increased risk of acute pancreatitis in alcohol-related liver disease compared to matched comparators: A population-based cohort study  Journal of Internal Medicine. 2025;297(2):213-226
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39655576

Systematic review on resting-state fMRI in people with AUD and people who binge drink  Molecular Psychiatry. 2025;30(2):752-762
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39448806

Vortioxetine improves illness severity for cannabis users with anxiety and depressive symptoms in a 6-month randomized controlled study  J Subst Use Addict Treat. 2025;169:209607
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39672338